SCORE Emerging Adult Cannabis Use & Stress

Part of paid clinical trials in Charleston, South Carolina.

Sponsor
Medical University of South Carolina
Study ID
NCT05885542
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

  • Cannabis Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - 25 Years
Healthy Volunteers
Not accepted

Interventions

  • Cannabidiol oral solution — DRUG
    Double-blind cannabidiol oral solution 800 mg administered once
  • Placebo — DRUG
    Double-blind placebo oral solution administered once

Study Details

The interface between cannabis use and stress is a particularly important focus for sex differences research in emerging adults. Given the dynamics at play in this critical stage when cannabis use is most prevalent, developmentally informed research is needed to guide tailored clinical interventions. This study will apply rigorous and innovative methods to elucidate sex differences in the nexus of cannabis use and stress among emerging adults with cannabis use disorder to guide the development of tailored treatments.

Key Dates

Start date
Nov 1, 2023
Status verified
Nov 2025
Primary completion
Jul 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
148 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: cannabidiol 800 mg
    Cannabidiol 800 mg will be administered orally once in the laboratory prior to a stress induction paradigm.
  • Placebo Comparator: placebo
    Placebo (formulated to appear identical to active condition) administered orally once in the laboratory prior to a stress induction paradigm.

Primary Outcome Measure

Cannabis withdrawal symptoms [ Time Frame: Assessed after 3-day cannabis abstinence period ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Medical University of South CarolinaCharlestonSouth Carolina29425
Sarah Bourne
843-876-2084
Kevin M Gray, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charleston, SC

Related Studies